497 related articles for article (PubMed ID: 14978513)
1. Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.
Verster JC; Volkerts ER
CNS Drug Rev; 2004; 10(1):45-76. PubMed ID: 14978513
[TBL] [Abstract][Full Text] [Related]
2. Panic disorder: long-term pharmacotherapy and discontinuation.
Rickels K; Schweizer E
J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):12S-18S. PubMed ID: 9872708
[TBL] [Abstract][Full Text] [Related]
3. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
Pecknold JC; Swinson RP; Kuch K; Lewis CP
Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
[TBL] [Abstract][Full Text] [Related]
4. Drug treatment of panic disorder.
Rosenberg R
Pharmacol Toxicol; 1993 Jun; 72(6):344-53. PubMed ID: 8103214
[TBL] [Abstract][Full Text] [Related]
5. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.
Klein E; Colin V; Stolk J; Lenox RH
Am J Psychiatry; 1994 Dec; 151(12):1760-6. PubMed ID: 7977882
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation reactions to alprazolam in panic disorder.
Pecknold JC
J Psychiatr Res; 1993; 27 Suppl 1():155-70. PubMed ID: 8145176
[TBL] [Abstract][Full Text] [Related]
7. Alprazolam (Xanax, and others) revisited.
Med Lett Drugs Ther; 2005 Jan; 47(1200):5-7. PubMed ID: 15647704
[TBL] [Abstract][Full Text] [Related]
8. A 15-year follow-up study of patients with panic disorder.
Andersch S; Hetta J
Eur Psychiatry; 2003 Dec; 18(8):401-8. PubMed ID: 14680716
[TBL] [Abstract][Full Text] [Related]
9. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
[TBL] [Abstract][Full Text] [Related]
10. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
11. Sertraline and alprazolam in the treatment of panic desorder.
Fiseković S; Loga-Zec S
Bosn J Basic Med Sci; 2005 May; 5(2):78-81. PubMed ID: 16053461
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature.
Jonas JM; Cohon MS
J Clin Psychiatry; 1993 Oct; 54 Suppl():25-45; discussion 46-8. PubMed ID: 8262888
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
[TBL] [Abstract][Full Text] [Related]
14. High-potency benzodiazepines for short-term management of panic disorder: the U.S. experience.
Tesar GE
J Clin Psychiatry; 1990 May; 51 Suppl():4-10; discussion 50-3. PubMed ID: 1970816
[TBL] [Abstract][Full Text] [Related]
15. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
Lydiard RB; Ballenger JC; Rickels K
J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
[TBL] [Abstract][Full Text] [Related]
16. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
Charney DS; Woods SW; Goodman WK; Rifkin B; Kinch M; Aiken B; Quadrino LM; Heninger GR
J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
[TBL] [Abstract][Full Text] [Related]
17. Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.
Sheikh JI; Swales PJ
Int J Psychiatry Med; 1999; 29(1):107-17. PubMed ID: 10376237
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
Andersch S; Rosenberg NK; Kullingsjö H; Ottosson JO; Bech P; Bruun-Hansen J; Hanson L; Lorentzen K; Mellergård M; Rasmussen S
Acta Psychiatr Scand Suppl; 1991; 365():18-27. PubMed ID: 1862730
[TBL] [Abstract][Full Text] [Related]
19. Efficacy studies of alprazolam in panic disorder.
Spiegel DA
Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
[TBL] [Abstract][Full Text] [Related]
20. Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepines.
Herman JB; Brotman AW; Rosenbaum JF
J Clin Psychiatry; 1987 Oct; 48 Suppl():22-8. PubMed ID: 2889722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
